NCT01073618View on ClinicalTrials.gov

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV

CompletedOBSERVATIONAL
Enrollment

692

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Serious Fungal Infections
Interventions
DRUG

voriconazole IV

6 mg/kg iv q 12 hours (loading) then maintenance

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY